CStone Pharmaceuticals Share Price OTC Markets
Stocks
CSPHF
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Delayed
OTC Markets
20:05:50 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.9109 USD | +33.09% |
|
0.00% | +2.00% |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| 08-31 | Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio | CI |
| Market Cap | 7.33B 1.09B 952M 901M 819M 1.53B 105B 1.54B 10.73B 4.15B 53.2B 4.11B 4.01B 170B | P/E 2026 * |
-15.9x | P/E 2027 * | 7.71x |
|---|---|---|---|---|---|
| Enterprise Value | 6.35B 947M 825M 781M 710M 1.33B 90.73B 1.33B 9.3B 3.6B 46.11B 3.56B 3.48B 148B | EV / Sales 2026 * |
15x | EV / Sales 2027 * | 1.92x |
| Free-Float |
79.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | +33.09% | ||
| Current month | +30.13% | ||
| 1 month | +30.13% | ||
| 3 months | +53.22% | ||
| 6 months | +5.77% | ||
| Current year | +2.00% |
| 1 month | 0.68 |  | 0.91 |
| Current year | 0.59 | | 1.01 |
| 1 year | 0.59 | | 1.01 |
| 3 years | 0.11 | | 1.01 |
| 5 years | 0.11 | | 1.58 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 24/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 17/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 31/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 24/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 08/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +33.09% | 0.00% | - | - | 1.06B | |
| +1.03% | -1.44% | +33.54% | -5.17% | 77.35B | |
| +1.81% | +3.71% | -12.06% | -33.66% | 59.58B | |
| +7.01% | +14.62% | +526.40% | +50.37% | 58.14B | |
| -0.92% | -3.86% | -12.36% | +24.21% | 47.62B | |
| +1.21% | +3.42% | +2.76% | +151.63% | 45.34B | |
| +0.76% | +1.04% | +50.25% | -14.07% | 31.92B | |
| +1.04% | +2.37% | +48.83% | +112.07% | 25.29B | |
| +2.18% | -2.09% | -0.10% | +145.28% | 20.88B | |
| +1.46% | +1.60% | +62.58% | +102.27% | 15.64B | |
| Average | +4.79% | +0.11% | +77.76% | +59.21% | 42.42B | |
| Weighted average by Cap. | +1.86% | +0.39% | +93.86% | +40.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 63.09M 54.96M 52.01M 47.26M 88.28M 6.04B 88.72M 620M 240M 3.07B 237M 232M 9.83B | 1.72B 257M 224M 212M 192M 359M 24.59B 361M 2.52B 975M 12.5B 965M 943M 40.01B |
| Net income | -384M -57.19M -49.81M -47.14M -42.83M -80.02M -5.48B -80.41M -562M -217M -2.78B -215M -210M -8.91B | 680M 101M 88.37M 83.64M 75.99M 142M 9.72B 143M 996M 385M 4.94B 381M 373M 15.81B |
| Net Debt | -978M -146M -127M -120M -109M -204M -13.96B -205M -1.43B -553M -7.1B -548M -535M -22.71B | -4.02B -600M -522M -494M -449M -839M -57.45B -843M -5.89B -2.28B -29.19B -2.25B -2.2B -93.46B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- CSPHF Stock
Select your edition
All financial news and data tailored to specific country editions
